[Use of experimental animals in the prediction of undesirable effects of nonsteroidal anti-inflammatory agents].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D013956:Antithyroid Agents; D002478:Cells, Cultured; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004285:Dogs; D003875:Drug Eruptions / Q000209:etiology; D004353:Drug Evaluation, Preclinical; D004342:Drug Hypersensitivity; D006168:Guinea Pigs; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D051379:Mice; D009422:Nervous System Diseases / Q000139:chemically induced; D009460:Neurologic Examination; D010396:Penicillamine / Q000009:adverse effects; D010437:Peptic Ulcer / Q000139:chemically induced; D010653:Phenylbutazone / Q000009:adverse effects / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013045:Species Specificity; D013844:Thiazoles / Q000009:adverse effects; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013956:Antithyroid Agents; D013844:Thiazoles; D010653:Phenylbutazone; D010396:Penicillamine
Apports de l'expérimentation animale dans la prévision des effets indésirables des médicaments anti-inflammatoires non stéroïdiens